NCT05647226View on ClinicalTrials.gov

Digital Diabetes Remission Trial

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 9, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
COMBINATION_PRODUCT

Digital therapeutic and intensive lifestyle programme

Initial 12-week LED and behaviour education app.

OTHER

Standard of care

Standard of care.

Trial Locations (1)

SE1 3ER

Lindus Health Ltd, London

Sponsors

Collaborators (1)

Lindus Health
All Listed Sponsors
collaborator

Lindus Health

INDUSTRY

lead

Habitual Health Ltd

INDUSTRY

NCT05647226 - Digital Diabetes Remission Trial | Biotech Hunter | Biotech Hunter